[HTML][HTML] Connexin hemichannels in astrocytes: role in CNS disorders
LY Xing, T Yang, SS Cui, G Chen - Frontiers in molecular …, 2019 - frontiersin.org
In the central nervous system (CNS), astrocytes form networks interconnected by gap
junctions made from connexins of the subtypes Cx30 and Cx43. When unopposed by an …
junctions made from connexins of the subtypes Cx30 and Cx43. When unopposed by an …
Neuraxial cytokines in pain states
G Gonçalves dos Santos, L Delay, TL Yaksh… - Frontiers in …, 2020 - frontiersin.org
A high-intensity potentially tissue-injuring stimulus generates a homotopic response to
escape the stimulus and is associated with an affective phenotype considered to represent …
escape the stimulus and is associated with an affective phenotype considered to represent …
[HTML][HTML] Sigmar1's molecular, cellular, and biological functions in regulating cellular pathophysiology
The Sigma 1 receptor (Sigmar1) is a ubiquitously expressed multifunctional inter-organelle
signaling chaperone protein playing a diverse role in cellular survival. Recessive mutation in …
signaling chaperone protein playing a diverse role in cellular survival. Recessive mutation in …
[HTML][HTML] Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain
MC Ruiz-Cantero, R González-Cano, MÁ Tejada… - Pharmacological …, 2021 - Elsevier
Immune and glial cells play a pivotal role in chronic pain. Therefore, it is possible that the
pharmacological modulation of neurotransmission from an exclusively neuronal perspective …
pharmacological modulation of neurotransmission from an exclusively neuronal perspective …
Enteric glia: a new player in abdominal pain
W Morales-Soto, BD Gulbransen - Cellular and molecular gastroenterology …, 2019 - Elsevier
Chronic abdominal pain is the most common gastrointestinal issue and contributes to the
pathophysiology of functional bowel disorders and inflammatory bowel disease. Current …
pathophysiology of functional bowel disorders and inflammatory bowel disease. Current …
Tonabersat prevents inflammatory damage in the central nervous system by blocking connexin43 hemichannels
The cis benzopyran compound tonabersat (SB-220453) has previously been reported to
inhibit connexin26 expression in the brain by attenuating the p38-mitogen-activated protein …
inhibit connexin26 expression in the brain by attenuating the p38-mitogen-activated protein …
Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice
S Castany, G Gris, JM Vela, E Verdú… - Scientific reports, 2018 - nature.com
Abstract Sigma-1 receptor (σ1R) knockout (KO) CD1 mice, generated by homologous
recombination, and separate pharmacological studies in wild type (WT) mice were done to …
recombination, and separate pharmacological studies in wild type (WT) mice were done to …
Sigma-1 receptor: A potential target for the development of antidepressants
YM Wang, CY Xia, HM Jia, J He, WW Lian… - Neurochemistry …, 2022 - Elsevier
Though a great many of studies on the development of antidepressants for the therapy of
major depression disorder (MDD) and the development of antidepressants have been …
major depression disorder (MDD) and the development of antidepressants have been …
[HTML][HTML] On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review
Spinal cord injury (SCI) is globally considered as one of the most debilitating disorders,
which interferes with daily activities and life of the affected patients. Despite many …
which interferes with daily activities and life of the affected patients. Despite many …
Connexin channels at the glio-vascular interface: gatekeepers of the brain
M De Bock, L Leybaert, C Giaume - Neurochemical research, 2017 - Springer
Neuronal survival, electrical signaling and synaptic activity require a well-balanced micro-
environment in the central nervous system. This is achieved by the blood–brain barrier …
environment in the central nervous system. This is achieved by the blood–brain barrier …